Leader in Lupus Research and Young Investigator Recognized for Exceptional Contributions and Dedication to Field

WASHINGTON, Nov. 10, 2019 /PRNewswire/ --A Today, the Lupus Foundation of America (LFA) is honored to recognize two leading lupus scientists for the significant impact they have made and continue to make in lupus research at the 2019 Evelyn V. Hess Reception, to be held this evening in Atlanta, GA during the 2019 American College of Rheumatology (ACR) Annual Scientific Meeting. This year, the LFA will present the Evelyn V. Hess Award to Judith James, MD, PhD, Oklahoma Medical Research Foundation (OMRF) and the Mary Betty Stevens Young Investigator Prize to Candace Feldman, MD, MPH, ScD, Brigham and Women's Hospital.
Leader in Lupus Research and Young Investigator Recognized for Exceptional Contributions and Dedication to Field
Honoring Dr. James for Groundbreaking Work and Dedication to Lupus ResearchThe Evelyn V. Hess Award was established in 2006 and is given annually to recognize the exceptional contributions of a clinical or basic researcher whose body of work has advanced the understanding of the science of lupus treatment.Dr. James, OMRF Vice President of Clinical Affairs, will be honored for her 25 years of accomplishments and contributions to the lupus research field. Her work has resulted in over 280 publications, and she has led or participated in over 25 clinical trials and has been awarded over 50 federally funded grant projects. One such project, conducted with the Department of Defense and National Institutes of Health funding, focused on assessing factors that have the potential to delay or prevent lupus onset in at-risk people. The study found that anti-malarial drugs could slow the accrual of new autoantibodies and progression of clinical lupus a?? laying the foundation for prevention trials in lupus and rheumatoid arthritis, which are ongoing at OMRF and other locations. Dr. James is recognized as a leader in the translational science of lupus and a pioneer in understanding the causes and early events of the disease. She has led the Oklahoma Autoimmunity Center of Excellence (ACE) over the past three funding cycles and served as principal investigator of the Oklahoma Rheumatic Disease Research Cores Center and Oklahoma Shared Clinical and Translational Resources.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Июль 2020    »